Merck and AstraZeneca say the United Kingdom is not spending enough on medicines, but experts say it’s a symptom of ...

FDA’s Dr. Martin Makary says drug ads have crossed the line and enforcement is needed, calling out pharmaceutical companies for spending 20-25% of their budgets on marketing.

One of the main factors driving prices in pharmaceuticals, such as cholesterol-lowering drugs and antibiotics, is the cost of ...

Teva Pharmaceutical Industries Limited (NYSE:TEVA), a global pharmaceutical company, continues its transition from a generics ...

In today’s Pharmaceutical Executive Daily, we cover Lilly’s orforglipron as a prime candidate for FDA fast-track approval, ...

President Donald Trump's memorandum seeks to enforce existing regulations ensuring transparency and accuracy in drug ...

CHAPPER healthcare, AscellaHealth’s global pharmaceutical wholesaler, distributor and commercialization service provider, ...

FDA warns major pharmaceutical companies to improve transparency in drug advertising, addressing misleading claims and ...

BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) is one of the best affordable biotech stocks to invest in now. On September 8, ...

The Cabinet of Ministers on Monday approved a major procurement package aimed at strengthening local pharmaceutical ...

The University College Hospital (UCH), Ibadan, has officially launched a Public-Private Partnership (PPP) with Medbury ...